SageView Advisory Group »

Anika Therapeutics shares owned by SageView Advisory Group

Quarter-by-quarter ownership of Anika Therapeutics (ANIK) shares owned by SageView Advisory Group from 13F filings

Historical chart of SageView Advisory Group investment in Anika Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Anika Therapeutics held by SageView Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anika Therapeutics by SageView Advisory Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.5k 465 9.61

More positions owned by SageView Advisory Group

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Index Fds Extend Mkt Etf (VXF)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Ishares Tr Core Intl Aggr (IAGG)
Ishares Tr Global Reit Etf (REET)
Schwab Strategic Tr Intl Sceqt Etf (SCHC)
Apple (AAPL)
Spdr Series Trust State Street Spd (SPHY)
Ishares Tr National Mun Etf (MUB)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for SageView Advisory Group

Top funds holding Anika Therapeutics

BlackRock
Caligan Partners
Vanguard Group
Acadian Asset Management
Boothbay Fund Management
Renaissance Technologies
Capital Management Corporation
Dimensional Fund Advisors
State Street Corporation
Geode Capital Management
Jacobs Levy Equity Management
D. E. Shaw & Co
Trigran Investments
Goldman Sachs Group
Jane Street

View all funds holding Anika Therapeutics